This program has been renamed in honor of Merrill J. Egorin who played a critical role in the development of the program and served as its co-chair until his death in the fall of 2010.
The 3-day workshop brings together 20-25 fellows and junior faculty (within 5 years of training completion) from the leading medical oncology, surgical oncology, radiation oncology, and surgical subspecialty fellowships in the United States
Co-Chaired by Ross Donehower (Johns Hopkins School of Medicine)and Jeffrey Engelman, (Harvard Medical School), the 16-member faculty includes researchers and educators from NCI, FDA, and the nation’s leading cancer centers. The course has received national recognition for its focused and practical approach to preparing individuals to conduct cancer drug research.
The broad-based curriculum covers a range of topics related to new drug development and clinical evaluation. Expert speakers will lead discussions and present important didactic information regarding the preclinical and clinical evaluation of cytotoxic and targeted drugs, the identification and use of biomarkers, the special challenges of evaluating combination therapies, the problem of pharmacodynamic and pharmacokinetic drug interactions, and effects of organ dysfunction on drug disposition and toxicity. The discussion will include a focus on validation of targets and confirmation of mechanism of action and resistance in clinical trials. The 20-25 scholars selected will have ample opportunity for one-on-one interface with the nationally renowned faculty as well as peer-to-peer networking. Specialized evening workshops will also include sessions on new drugs, utility of biomarkers for selection of subjects and for prediction of response, and late breaking developments in cancer therapeutics.
This program is supported by the nonprofit sector and individual contributions from faculty, Trustees and alumni
Workshop Dates: Fall 2014 TBD
Location: Lansdowne Conference Center; Leesburg, Virginia
Application Deadline: June 15, 2014
Notification: July 1, 2014